背景在克罗恩病患者中，英夫利西单抗和硫唑嘌呤单药治疗或联合治疗的相对疗效和安全性尚未被了解。
Background the comparative efficacy and safety of infliximab and azathioprine therapy alone or in combination for Crohn's disease are unknown.
免疫抑制剂时的条件是难以控制或是很困难的，以减少您的口服类固醇剂量，没有复发，免疫抑制剂，如硫唑嘌呤或巯基嘌呤是使用。
Immunosuppressants When the condition is difficult to control or it is difficult to reduce your oral steroid dose without relapse, an immunosuppressant such as azathioprine or mercaptopurine is used.
在免疫受到抑制的病人可发生此病，患者因移植、白血病或淋巴瘤而常应用激素、硫唑嘌呤或细胞毒类药物治疗者。
This is seen in immunosuppressed patients usually on steroids, azathioprine, or cytotoxic agents following transplantation or for leukaemia or lymphoma.
在免疫受到抑制的病人可发生此病，患者因移植、白血病或淋巴瘤而常应用激素、硫唑嘌呤或细胞毒类药物治疗者。
This is seen in immunosuppressed patients usually on steroids, azathioprine, or cytotoxic agents following transplantation or for leukaemia or lymphoma.
应用推荐